0001810038-26-000003.txt : 20260526 0001810038-26-000003.hdr.sgml : 20260526 20260526110936 ACCESSION NUMBER: 0001810038-26-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260526 DATE AS OF CHANGE: 20260526 EFFECTIVENESS DATE: 20260526 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cancer IQ Inc. CENTRAL INDEX KEY: 0001810038 ORGANIZATION NAME: EIN: 461976149 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-496976 FILM NUMBER: 261017075 BUSINESS ADDRESS: STREET 1: 515 N. STATE STREET STREET 2: SUITE 1075 CITY: CHICAGO STATE: IL ZIP: 60654 BUSINESS PHONE: (312) 761-3360 MAIL ADDRESS: STREET 1: 515 N. STATE STREET STREET 2: SUITE 1075 CITY: CHICAGO STATE: IL ZIP: 60654 D/A 1 primary_doc.xml X0708 D/A LIVE 0001810038 Cancer IQ Inc. 2045 W Grand Avenue Ste B PMB 404765 CHICAGO IL ILLINOIS 60612 (312) 761-3360 DELAWARE None None Corporation true Olufeyikemi Olopade Ayodele 2045 W Grand Avenue Ste B PMB 404765 Chicago IL ILLINOIS 60612 Executive Officer Director Mark Bakken 2045 W Grand Avenue Ste B PMB 404765 Chicago IL ILLINOIS 60612 Director Joel Krikston 2045 W Grand Avenue Ste B PMB 404765 Chicago IL ILLINOIS 60612 Director Haibo Lu 2045 W Grand Avenue Ste B PMB 404765 Chicago IL ILLINOIS 60612 Executive Officer Director Carladenise Edwards 2045 W Grand Avenue Ste B PMB 404765 Chicago IL ILLINOIS 60612 Director Other Technology Decline to Disclose 06b true 0001810038-23-000001 2023-11-01 true true true true false 0 6000000 4284000 1716000 false 9 0 0 0 false Cancer IQ Inc. /s/ Olufeyikemi Olopade Ayodel Olufeyikemi Olopade Ayodele Chief Executive Officer 2026-05-26